Clorox Co. stock (US1890541097): CEO transition and outlook cut weigh on NYSE-listed shares

Clorox Co. shares remain under notable pressure on the New York Stock Exchange after a sharp sell-off tied to a leadership change and a lowered earnings outlook, leaving the United States household-products company trading well below prior levels as investors reassess its medium-term trajectory.

According to market data compiled on 05/29/2026, The Clorox Company (ticker: CLX) closed around USD 90 per share on the NYSE, down roughly 6 % on the day and extending a decline of more than 25 % over the past twelve months. The move follows fresh headlines that CEO Linda Rendle plans to step down for health reasons and comes on top of an April 2026 update where the group lowered its guidance for FY2026 diluted EPS to a range of USD 4.78 to USD 4.98 from a previously higher outlook, underscoring the home-country focus on the US-listed stock.

The stock traded at USD 90.02 on 05/29/2026 on the NYSE, according to GuruFocus as of 05/29/2026.

As of: 05/30/2026

By the editorial team - specialized in equity coverage.

Clorox Co.: core business model

Clorox Co. focuses on branded household and cleaning products across categories such as disinfecting wipes, bleach and other home-care items, generating most of its revenue from consumer staples sold through retail and e-commerce channels in the United States and selected international markets.

Recent corporate actions

Beyond the share-price weakness, the company has been in the spotlight for corporate developments including the planned departure of CEO Linda Rendle, whose exit is linked to health reasons, adding governance and succession considerations at a time when the business is already adapting to a more cautious earnings outlook. In April 2026, Clorox cut its FY2026 diluted EPS guidance to USD 4.78 to USD 4.98, framing expectations for the current year and implying pressure from cost dynamics and competitive intensity in its core cleaning and household segments, according to analysis that referenced the company’s updated outlook. Investor positioning is also shifting, with Legal & General Group Plc disclosing a reduced stake in Clorox in a late-May 2026 filing, signaling some institutional recalibration in response to the changing risk profile.

Insider activity and ownership structure

While direct insider transactions by executives have not dominated the recent newsflow, ownership disclosures show activity among major institutional holders, which forms a key part of the broader shareholding structure for Clorox Co. as a US-listed blue chip in the consumer staples space. In a filing highlighted on 05/30/2026, Legal & General Group Plc reported that it had reduced its position in The Clorox Company, a move that coincided with the stock trading down about 6.5 % and opening at USD 89.98 on that day, illustrating how large asset managers are adjusting their exposure during a period of leadership transition and moderated earnings expectations. These shifts in institutional holdings sit alongside a long-standing base of mutual funds and index trackers that typically anchor ownership in well-known US consumer brands.

Conclusion

Clorox Co. is entering a complex phase as a US consumer-staples name, with a share price around USD 90, a planned CEO change and a lower FY2026 EPS range of USD 4.78 to USD 4.98 now framing how investors view its near-term prospects. The recent adjustment in holdings by a major institutional investor such as Legal & General Group Plc underlines how ownership patterns are responding to these developments, adding another dimension to the market’s assessment of risk and resilience for the NYSE-listed stock. How effectively the company manages leadership succession and delivers on its updated guidance will likely be central to sentiment in the coming quarters.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.